Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering

NCT04914507 · View on ClinicalTrials.gov ↗

Study Summary

Anterior vertebral body tethering (AVBT) is a novel, minimally invasive, growth modulation technique that was recently approved by the FDA under a Humanitarian Device Exemption (HDE). The goal of AVBT is to control curve progression by applying compression on the convex side of the spine deformity. While there has been great initial enthusiasm about the technique as an alternate treatment option to spinal fusion for skeletally immature children with scoliosis, there is a need to better understand the long-term outcomes. The purpose of this study is to report the long-term clinical outcomes of skeletally immature patients treated with AVBT, specifically: 1. The effect on three-dimensional spine growth as compared to normal controls 2. Maintenance of major Cobb angle less than or equal to 50 degrees at skeletal maturity 3. Complications associated with both the procedure and the device

Conditions Studied

Interventions

  • DEVICE Anterior Vertebral Body Tethering

Study Locations (12)

District of Columbia

  • Children's National Hospital — Washington D.C.

Illinois

  • Shriners Children's Chicago — Chicago

Minnesota

  • Gillette Children's Specialty Healthcare — Saint Paul

Missouri

  • Washington University — St Louis

New York

  • Morgan Stanley Childrens Hospital of New York-Presbyterian — New York

Ohio

  • Cincinnati Children's Hospital Medical Center — Cincinnati

Oregon

  • Shriners Children's Portland — Portland

Pennsylvania

  • Children's Hospital of Philadelphia — Philadelphia

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2021-09-09
Est. Completion 2029-09
Phase NA

Sponsor

Pediatric Spine Foundation

29 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04914507

The ClinicalTrials.gov registry entry for NCT04914507 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatric Spine Foundation, which has 29 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Scoliosis Idiopathic appearing as the primary indexed condition, and to 1 intervention — of which Anterior Vertebral Body Tethering is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT04914507 reports 12 study locations spanning 12 distinct geographic areas — top geographies include District of Columbia, Illinois, Minnesota. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT04914507 about?

NCT04914507 is a clinical study titled "A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering". Anterior vertebral body tethering (AVBT) is a novel, minimally invasive, growth modulation technique that was recently approved by the FDA under a Humanitarian Device Exemption (HDE). The goal of AVBT is to control curve progression by applying compression on the convex side of the spine deformity. ...

What is the current status of trial NCT04914507?

This trial is currently recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2021-09-09. Estimated completion is 2029-09.

What conditions does trial NCT04914507 study?

This clinical trial studies the following conditions: Scoliosis Idiopathic. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT04914507?

The interventions under investigation include: Anterior Vertebral Body Tethering (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT04914507?

This trial is sponsored by Pediatric Spine Foundation, which has 29 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT04914507 being conducted?

This trial has 12 study locations across District of Columbia, Illinois, Minnesota, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial